Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-01

Clinical Trial Update: Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas

View source ↗

Summary

Clinical trial update on using radiofrequency ablation to treat low-risk papillary thyroid microcarcinoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Premier G Med Cardio Kft | Conditions: Papillary Thyroid Microcarcinoma | Status: COMPLETED